WASHINGTON, Feb. 21, 2017 /PRNewswire-USNewswire/ -- The Pharmaceutical Research and Manufacturers of America (PhRMA) will sponsor its first national health care dialogue series today in Boston, Massachusetts. The Atlantic will convene this inaugural conversation, titled: "Through the Microscope: Examining Modern Medicine." The event will explore the transformation of patient care and the science that has revolutionized medical breakthroughs, new treatments and technologies, as well as the investments needed for future innovation.
Today's event is the first in a national dialogue series PhRMA is supporting as part of its new GOBOLDLY campaign. The events and programming will include a cross-section of industry stakeholders and health care thought leaders, including world-renowned scientists, researchers and other experts.
"Many of the groundbreaking advancements in medicine are happening right here in Boston's thriving health care community, where scientists and researchers are transforming patient care," said Stephen J. Ubl, president and chief executive officer of PhRMA. "We are in a new era of medicine and now is the time to convene a substantial forward-looking conversation on ways we can work together to build upon this scientific progress."
Dr. Laurie Glimcher, CEO of the Dana-Farber Cancer Institute will deliver the keynote address. Mr. Ubl will participate in an underwriter series one-on-one conversation with Joe Shortsleeve, Emmy award winning journalist and long-time anchor and investigative reporter at Boston's WBZ.
Leading biopharmaceutical scientists participating in the panel discussions include Dr. Daniel Skovronsky, the senior vice president of Drug Development at Eli Lilly and Gilmore O'Neill, the senior vice president of the Drug Innovation Units at Biogen. The full agenda and slate of speakers can be found here.
Watch the event livestream at: https://www.theatlantic.com/live/events/through-the-microscope-examining-modern-medicine/2017/ and follow the conversation on Twitter at #GoBoldly and #AtlanticMedicine.
For reporters interested in broadcast quality video, audio and photo stills, please contact email@example.com.
For reporters interested in speaking with The Atlantic, please contact Sydney Simon at firstname.lastname@example.org.
The Pharmaceutical Research and Manufacturers of America (PhRMA) represents the country's leading innovative biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier and more productive lives. Since 2000, PhRMA member companies have invested more than half a trillion dollars in the search for new treatments and cures, including an estimated $58.8 billion in 2015 alone.
Contact: Priscilla VanderVeer
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/phrma-kicks-off-national-health-care-dialogue-to-examine-the-new-era-of-medicine-300410579.html
SOURCE Pharmaceutical Research and Manufacturers of America (PhRMA)